Apollo Intelligence Wins 2024 Artificial Intelligence Excellence Award

With NLP and ML features in the Apollo Intelligence Next-Generation Platform for Market Insights, life science firms can gain significantly greater speed to insights and higher quality data

March 20, 2024 09:00 AM Eastern Daylight Time

WATERTOWN, Mass.–(BUSINESS WIRE)–Apollo Intelligence (Apollo), a leading provider of real-time data and insights to the healthcare and life science industries, was named a winner in the 2024 Artificial Intelligence Excellence Awards program by the Business Intelligence Group. Apollo’s Next-Generation Platform for Market Insights was recognized in the Natural Language Processing (NLP) category. With today’s fast pace and shifting market dynamics, and the risks associated with achieving anything less than optimal results, Apollo’s next-gen platform delivers a unique combination of high-quality data and speed to insight that is unmatched in the market.

“We are thrilled that our next-gen platform is being recognized for delivering fast, efficient, and high-quality market research at scale.”Post this

In the past 12 months, Apollo’s next-gen platform increased speed-to-insights by 25%, improved physician member profile depth by 34%, and delivered eight game-changing NLP and machine learning (ML) and analytics-enabled features. These include a first of its kind adverse event feature using NLP to help flag open-end, verbatim survey answers that may represent adverse events that require FDA reporting.

“Apollo has a track record of leveraging technology to unlock new learning and transform life science market insights, and adding AI technologies within our platform continues this commitment,” said Daniel S. Fitzgerald, CEO and president of Apollo. “We are thrilled that our next-gen platform is being recognized for delivering fast, efficient, and high-quality market research at scale.”

About Apollo Intelligence, LLC

Apollo’s mission is to accelerate health innovation to improve life. In 2019, Apollo launched with the acquisition of InCrowd, a pioneer of real-time, automated insights for the life science industry. In 2020, Apollo strengthened its global reach by acquiring Survey Healthcare Global, a market leader in first-party healthcare data collection and custom survey solutions. In 2024, Apollo acquired GlocalMind, a global technology-driven healthcare market research services and panel company, expanding its reach in Europe and APAC while enhancing follow-the-sun life science market insights efficiencies. Through these unique firms, Apollo provides access to two million healthcare stakeholders worldwide—physicians, KOLs, patients, caregivers, and allied healthcare professionals. Apollo’s 300+ employees support top global pharmaceutical and healthcare brands, market research agencies, and consultancies across 13 countries in the Americas, Europe, and Asia. Apollo is a portfolio company of Frazier Healthcare Partners. For more information about Apollo, please visit our website at www.apollointelligence.net.